nodes	percent_of_prediction	percent_of_DWPC	metapath
Carvedilol—GJA1—skin epidermis—vulva cancer	0.0755	0.0755	CbGeAlD
Carvedilol—SELE—epithelium—vulva cancer	0.0287	0.0287	CbGeAlD
Carvedilol—SELE—uterine cervix—vulva cancer	0.0284	0.0284	CbGeAlD
Carvedilol—VCAM1—epithelium—vulva cancer	0.0264	0.0264	CbGeAlD
Carvedilol—VCAM1—uterine cervix—vulva cancer	0.0261	0.0261	CbGeAlD
Carvedilol—SELE—urethra—vulva cancer	0.0261	0.0261	CbGeAlD
Carvedilol—HIF1A—epithelium—vulva cancer	0.0254	0.0254	CbGeAlD
Carvedilol—HIF1A—uterine cervix—vulva cancer	0.0251	0.0251	CbGeAlD
Carvedilol—SELE—mammalian vulva—vulva cancer	0.0249	0.0249	CbGeAlD
Carvedilol—GJA1—epithelium—vulva cancer	0.0246	0.0246	CbGeAlD
Carvedilol—GJA1—uterine cervix—vulva cancer	0.0244	0.0244	CbGeAlD
Carvedilol—VCAM1—urethra—vulva cancer	0.024	0.024	CbGeAlD
Carvedilol—HIF1A—urethra—vulva cancer	0.0231	0.0231	CbGeAlD
Carvedilol—VCAM1—mammalian vulva—vulva cancer	0.0229	0.0229	CbGeAlD
Carvedilol—GJA1—urethra—vulva cancer	0.0224	0.0224	CbGeAlD
Carvedilol—HIF1A—mammalian vulva—vulva cancer	0.022	0.022	CbGeAlD
Carvedilol—NDUFC2—epithelium—vulva cancer	0.0214	0.0214	CbGeAlD
Carvedilol—GJA1—mammalian vulva—vulva cancer	0.0213	0.0213	CbGeAlD
Carvedilol—NDUFC2—uterine cervix—vulva cancer	0.0212	0.0212	CbGeAlD
Carvedilol—NDUFC2—urethra—vulva cancer	0.0195	0.0195	CbGeAlD
Carvedilol—VEGFA—uterine cervix—vulva cancer	0.0193	0.0193	CbGeAlD
Carvedilol—SELE—vagina—vulva cancer	0.0193	0.0193	CbGeAlD
Carvedilol—NDUFC2—mammalian vulva—vulva cancer	0.0186	0.0186	CbGeAlD
Carvedilol—CYP1A1—skin epidermis—vulva cancer	0.0183	0.0183	CbGeAlD
Carvedilol—VCAM1—vagina—vulva cancer	0.0177	0.0177	CbGeAlD
Carvedilol—VEGFA—urethra—vulva cancer	0.0177	0.0177	CbGeAlD
Carvedilol—XDH—uterine cervix—vulva cancer	0.0171	0.0171	CbGeAlD
Carvedilol—HIF1A—vagina—vulva cancer	0.017	0.017	CbGeAlD
Carvedilol—VEGFA—mammalian vulva—vulva cancer	0.0169	0.0169	CbGeAlD
Carvedilol—GJA1—vagina—vulva cancer	0.0165	0.0165	CbGeAlD
Carvedilol—XDH—mammalian vulva—vulva cancer	0.015	0.015	CbGeAlD
Carvedilol—NDUFC2—vagina—vulva cancer	0.0144	0.0144	CbGeAlD
Carvedilol—VEGFA—vagina—vulva cancer	0.0131	0.0131	CbGeAlD
Carvedilol—ADRA1D—epithelium—vulva cancer	0.0127	0.0127	CbGeAlD
Carvedilol—SELE—lymph node—vulva cancer	0.0125	0.0125	CbGeAlD
Carvedilol—XDH—vagina—vulva cancer	0.0116	0.0116	CbGeAlD
Carvedilol—ADRA1D—urethra—vulva cancer	0.0116	0.0116	CbGeAlD
Carvedilol—VCAM1—lymph node—vulva cancer	0.0115	0.0115	CbGeAlD
Carvedilol—HIF1A—lymph node—vulva cancer	0.011	0.011	CbGeAlD
Carvedilol—GJA1—lymph node—vulva cancer	0.0107	0.0107	CbGeAlD
Carvedilol—NDUFC2—lymph node—vulva cancer	0.00931	0.00931	CbGeAlD
Carvedilol—VEGFA—lymph node—vulva cancer	0.00844	0.00844	CbGeAlD
Carvedilol—ADRA1A—epithelium—vulva cancer	0.00729	0.00729	CbGeAlD
Carvedilol—KCNH2—uterine cervix—vulva cancer	0.00698	0.00698	CbGeAlD
Carvedilol—ADRA2C—uterine cervix—vulva cancer	0.00689	0.00689	CbGeAlD
Carvedilol—KCNH2—urethra—vulva cancer	0.00641	0.00641	CbGeAlD
Carvedilol—ADRA2C—urethra—vulva cancer	0.00633	0.00633	CbGeAlD
Carvedilol—ADRA2C—mammalian vulva—vulva cancer	0.00603	0.00603	CbGeAlD
Carvedilol—CYP1A1—epithelium—vulva cancer	0.00595	0.00595	CbGeAlD
Carvedilol—CYP1A1—uterine cervix—vulva cancer	0.00589	0.00589	CbGeAlD
Carvedilol—ADRA2A—uterine cervix—vulva cancer	0.0055	0.0055	CbGeAlD
Carvedilol—CYP1A1—urethra—vulva cancer	0.00542	0.00542	CbGeAlD
Carvedilol—PTGS1—epithelium—vulva cancer	0.00522	0.00522	CbGeAlD
Carvedilol—PTGS1—uterine cervix—vulva cancer	0.00518	0.00518	CbGeAlD
Carvedilol—CYP1A1—mammalian vulva—vulva cancer	0.00516	0.00516	CbGeAlD
Carvedilol—ADRA2A—urethra—vulva cancer	0.00505	0.00505	CbGeAlD
Carvedilol—CYP2E1—urethra—vulva cancer	0.00494	0.00494	CbGeAlD
Carvedilol—ADRA2A—mammalian vulva—vulva cancer	0.00481	0.00481	CbGeAlD
Carvedilol—KCNH2—vagina—vulva cancer	0.00473	0.00473	CbGeAlD
Carvedilol—ADRA2C—vagina—vulva cancer	0.00467	0.00467	CbGeAlD
Carvedilol—PTGS1—mammalian vulva—vulva cancer	0.00453	0.00453	CbGeAlD
Carvedilol—CYP1A1—vagina—vulva cancer	0.00399	0.00399	CbGeAlD
Carvedilol—ADRA2A—vagina—vulva cancer	0.00372	0.00372	CbGeAlD
Carvedilol—PTGS1—vagina—vulva cancer	0.00351	0.00351	CbGeAlD
Carvedilol—ABCB1—epithelium—vulva cancer	0.00309	0.00309	CbGeAlD
Carvedilol—ABCB1—uterine cervix—vulva cancer	0.00306	0.00306	CbGeAlD
Carvedilol—KCNH2—lymph node—vulva cancer	0.00306	0.00306	CbGeAlD
Carvedilol—ADRA2C—lymph node—vulva cancer	0.00302	0.00302	CbGeAlD
Carvedilol—ABCB1—urethra—vulva cancer	0.00281	0.00281	CbGeAlD
Carvedilol—ABCB1—mammalian vulva—vulva cancer	0.00268	0.00268	CbGeAlD
Carvedilol—CYP1A1—lymph node—vulva cancer	0.00258	0.00258	CbGeAlD
Carvedilol—ADRA2A—lymph node—vulva cancer	0.00241	0.00241	CbGeAlD
Carvedilol—PTGS1—lymph node—vulva cancer	0.00227	0.00227	CbGeAlD
Carvedilol—ABCB1—vagina—vulva cancer	0.00207	0.00207	CbGeAlD
Carvedilol—ABCB1—lymph node—vulva cancer	0.00134	0.00134	CbGeAlD
